Pharmacological perturbation of splicing elicits SMG1 reduction: Implications for cancer therapy.

The combination of SMG1 knockout and MS023 treatment showed a further trend toward tumor growth delay, although this did not reach statistical significance, suggesting limited additive effects ( Figures 1 C–1E).

also in 111,027 other papers